Who is sponsoring NCT00326365?

NCT00326365 is sponsored by Shaare Zedek Medical Center.

What condition does NCT00326365 study?

NCT00326365 studies Mechanically Ventilated ICU Patients.

What drugs are being tested in NCT00326365?

Interventions: Kali bichromicum 10-60 (C30).

What is the status of NCT00326365?

NCT00326365 is currently UNKNOWN.

Last reviewed 2007-10-30 · How we verify

A Multicenter, Randomized, Double Blind, Placebo Controlled Trial to Investigate the Efficacy and Safety of the Homeopathic Remedy Kalium Bichromicum (Potassium Dichromate) to Decrease Viscosity and Amount of Sputum as Well as Time to Extubation, in Intubated Mechanically Ventilated ICU Patients.

NCT00326365 Phase 3 UNKNOWN

The purpose of this study is to determine whether the homeopathic remedy Kali Bichromium is effective in reducing the amount of tracheal secretions in patients intubated with a conventional endotracheal tube and receiving controlled mechanical ventilation in the ICU setting.

Details

Lead sponsor	Shaare Zedek Medical Center
Phase	Phase 3
Status	UNKNOWN
Enrolment	56
Start date	2006-06

Conditions

Mechanically Ventilated ICU Patients

Interventions

Kali bichromicum 10-60 (C30)

Primary outcomes

To compare efficacy of Kali bichromicum (C30) in reducing tracheal secretions in mechanically ventilated patients

Countries

Israel